Biblio
Autologous Hematopoietic Stem Cell Therapy in Severe Systemic Sclerosis: Ready for Clinical Practice?. JAMA. 2014;311(24):2485-2487.
. Lymphocyte subset abnormalities in early severe scleroderma favor a Th2 phenotype and are not altered by prior immunosuppressive therapy. Rheumatology (Oxford). 2022.
Management of systemic sclerosis-associated interstitial lung disease. Curr Opin Rheumatol. 2019.
. Systemic sclerosis: a systematic review on therapeutic management from 2011 to 2014. Curr Opin Rheumatol. 2015.
.